Crestone Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,088
Closed -$318K 124
2023
Q3
$318K Buy
+3,088
New +$333K 0.08% 73
2020
Q2
Sell
-3,345
Closed -$246K 76
2020
Q1
$246K Buy
+3,345
New +$263K 0.1% 52
2017
Q3
Sell
-3,980
Closed -$243K 49
2017
Q2
$243K Buy
+3,980
New +$242K 0.11% 40

Other funds holding MRK

Crestone Asset Management's MRK Position: Q4 2023 in Review

Crestone Asset Management sold out of Merck (MRK) in Q4 2023, closing a stake of 3,088 shares — an estimated $318K sold.

Crestone Asset Management first reported a position in MRK in Q2 2017 and held it in 3 quarters. The position peaked at $318K in Q3 2023. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Crestone Asset Management reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • Crestone Asset Management sold 3,088 Merck shares in Q4 2023, an estimated $318K.
  • Crestone Asset Management first reported a position in Merck in Q2 2017 and held it in 3 quarters.
  • Crestone Asset Management's Merck position peaked at $318K in Q3 2023.
  • 3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Crestone Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.